Report Detail

Pharma & Healthcare Global DNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3664768
  • |
  • 27 August, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Scope of the Report:
North America is the largest consumption place, with a revenue market share nearly 58% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 28% in 2017. Asia-Pacific is also an important sales area, especially in China.
The worldwide market for DNA Vaccines is expected to grow at a CAGR of roughly 8.3% over the next five years, will reach 5490 million US$ in 2024, from 3690 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the DNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Recombinant Protein Vaccine
Gene-Based Vaccine

Market Segment by Applications, can be divided into
Human
Animal

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DNA Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of DNA Vaccines, with price, sales, revenue and global market share of DNA Vaccines in 2017 and 2018.
Chapter 3, the DNA Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DNA Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, DNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe DNA Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 DNA Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Recombinant Protein Vaccine
      • 1.2.2 Gene-Based Vaccine
    • 1.3 Market Analysis by Applications
      • 1.3.1 Human
      • 1.3.2 Animal
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Merck
      • 2.1.1 Business Overview
      • 2.1.2 DNA Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Merck DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 DNA Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Sanofi
      • 2.3.1 Business Overview
      • 2.3.2 DNA Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Sanofi DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Zoties
      • 2.4.1 Business Overview
      • 2.4.2 DNA Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Zoties DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Elanco
      • 2.5.1 Business Overview
      • 2.5.2 DNA Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Elanco DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Boehringer-Ingelheim
      • 2.6.1 Business Overview
      • 2.6.2 DNA Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Indian Immunologicals
      • 2.7.1 Business Overview
      • 2.7.2 DNA Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Indian Immunologicals DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Plumbline Life Sciences
      • 2.8.1 Business Overview
      • 2.8.2 DNA Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Plumbline Life Sciences DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global DNA Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global DNA Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global DNA Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 DNA Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 DNA Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global DNA Vaccines Market Analysis by Regions

    • 4.1 Global DNA Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global DNA Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global DNA Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America DNA Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa DNA Vaccines Sales and Growth Rate (2014-2019)

    5 North America DNA Vaccines by Country

    • 5.1 North America DNA Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States DNA Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada DNA Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico DNA Vaccines Sales and Growth Rate (2014-2019)

    6 Europe DNA Vaccines by Country

    • 6.1 Europe DNA Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia DNA Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy DNA Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific DNA Vaccines by Country

    • 7.1 Asia-Pacific DNA Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India DNA Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia DNA Vaccines Sales and Growth Rate (2014-2019)

    8 South America DNA Vaccines by Country

    • 8.1 South America DNA Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil DNA Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina DNA Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia DNA Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa DNA Vaccines by Countries

    • 9.1 Middle East and Africa DNA Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa DNA Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa DNA Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria DNA Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa DNA Vaccines Sales and Growth Rate (2014-2019)

    10 Global DNA Vaccines Market Segment by Type

    • 10.1 Global DNA Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global DNA Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global DNA Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Recombinant Protein Vaccine Sales Growth and Price
      • 10.2.1 Global Recombinant Protein Vaccine Sales Growth (2014-2019)
      • 10.2.2 Global Recombinant Protein Vaccine Price (2014-2019)
    • 10.3 Gene-Based Vaccine Sales Growth and Price
      • 10.3.1 Global Gene-Based Vaccine Sales Growth (2014-2019)
      • 10.3.2 Global Gene-Based Vaccine Price (2014-2019)

    11 Global DNA Vaccines Market Segment by Application

    • 11.1 Global DNA Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Human Sales Growth (2014-2019)
    • 11.3 Animal Sales Growth (2014-2019)

    12 DNA Vaccines Market Forecast (2019-2024)

    • 12.1 Global DNA Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 DNA Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America DNA Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe DNA Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific DNA Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America DNA Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa DNA Vaccines Market Forecast (2019-2024)
    • 12.3 DNA Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global DNA Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global DNA Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 DNA Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global DNA Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global DNA Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on DNA Vaccines. Industry analysis & Market Report on DNA Vaccines is a syndicated market report, published as Global DNA Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of DNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,794.44
      4,191.66
      5,588.88
      3,253.80
      4,880.70
      6,507.60
      539,852.40
      809,778.60
      1,079,704.80
      290,058.00
      435,087.00
      580,116.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report